Correlation Between Adagene and Sutro Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adagene and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adagene and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adagene and Sutro Biopharma, you can compare the effects of market volatilities on Adagene and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adagene with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adagene and Sutro Biopharma.

Diversification Opportunities for Adagene and Sutro Biopharma

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Adagene and Sutro is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Adagene and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Adagene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adagene are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Adagene i.e., Adagene and Sutro Biopharma go up and down completely randomly.

Pair Corralation between Adagene and Sutro Biopharma

Given the investment horizon of 90 days Adagene is expected to generate 0.79 times more return on investment than Sutro Biopharma. However, Adagene is 1.27 times less risky than Sutro Biopharma. It trades about 0.01 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.01 per unit of risk. If you would invest  212.00  in Adagene on September 2, 2025 and sell it today you would lose (11.00) from holding Adagene or give up 5.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.46%
ValuesDaily Returns

Adagene  vs.  Sutro Biopharma

 Performance 
       Timeline  
Adagene 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Adagene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Adagene is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Sutro Biopharma 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Sutro Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Sutro Biopharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Adagene and Sutro Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Adagene and Sutro Biopharma

The main advantage of trading using opposite Adagene and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adagene position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.
The idea behind Adagene and Sutro Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios